Study finds benefits in patients with CLL combining Imbruvica with CAR Tcell therapy httpswww.firstwordpharma.comnode1608602Â ASH18

Study finds benefits in patients with CLL combining Imbruvica with CAR T-cell therapy https://www.firstwordpharma.com/node/1608602  #ASH18

17:23 EST 2 Dec 2018 | FirstWord Pharma

Study finds benefits in patients with CLL combining Imbruvica with CAR T-cell therapy https://www.firstwordpharma.com/node/1608602  #ASH18

More From BioPortfolio on "Study finds benefits in patients with CLL combining Imbruvica with CAR T-cell therapy https://www.firstwordpharma.com/node/1608602  #ASH18"